APA Style
Hassan, S. O. A. , Hassan, S. O. A. Hassan, A. N. E. , Hassan, A. N. E. Mohamed, M. S. , Mohamed, M. S. Nessim, M. M. , Nessim, M. M. Ashram, M. N. B. A. , & Ashram, M. N. B. A. (2023). Role of Probiotics and Colchicine in COVID-19 Management?.
Universal Journal of Stomatology, 1(1), 14-16.
https://doi.org/10.31586/ujgh.2023.772
ACS Style
Hassan, S. O. A. ; Hassan, S. O. A. Hassan, A. N. E. ; Hassan, A. N. E. Mohamed, M. S. ; Mohamed, M. S. Nessim, M. M. ; Nessim, M. M. Ashram, M. N. B. A. ; Ashram, M. N. B. A. Role of Probiotics and Colchicine in COVID-19 Management?.
Universal Journal of Stomatology 2023 1(1), 14-16.
https://doi.org/10.31586/ujgh.2023.772
Chicago/Turabian Style
Hassan, Samar Osama Ahmed, Samar Osama Ahmed Hassan. Ahmed Nour El-Din Hassan, Ahmed Nour El-Din Hassan. Manal Sabry Mohamed, Manal Sabry Mohamed. Mina Mikhail Nessim, Mina Mikhail Nessim. Mohamed Nabil Badawy Al Ashram, and Mohamed Nabil Badawy Al Ashram. 2023. "Role of Probiotics and Colchicine in COVID-19 Management?".
Universal Journal of Stomatology 1, no. 1: 14-16.
https://doi.org/10.31586/ujgh.2023.772
AMA Style
Hassan SOA, Hassan SOAHassan ANE, Hassan ANEMohamed MS, Mohamed MSNessim MM, Nessim MMAshram MNBA, Ashram MNBA. Role of Probiotics and Colchicine in COVID-19 Management?.
Universal Journal of Stomatology. 2023; 1(1):14-16.
https://doi.org/10.31586/ujgh.2023.772
@Article{ujs772,
AUTHOR = {Hassan, Samar Osama Ahmed and Hassan, Ahmed Nour El-Din and Mohamed, Manal Sabry and Nessim, Mina Mikhail and Ashram, Mohamed Nabil Badawy Al and Allam, Mohamed Farouk},
TITLE = {Role of Probiotics and Colchicine in COVID-19 Management?},
JOURNAL = {Universal Journal of Stomatology},
VOLUME = {1},
YEAR = {2023},
NUMBER = {1},
PAGES = {14-16},
URL = {https://www.scipublications.com/journal/index.php/UJGH/article/view/772},
ISSN = {ISSN Pending},
DOI = {10.31586/ujgh.2023.772},
ABSTRACT = {Background: Coronavirus disease 2019 (COVID-19) is a newly emerging human disease caused by a novel coronavirus, causing a global pandemic crisis. Probiotics and/or colchicine may be considered as options for treatment since they have anti-viral, anti-inflammatory, and immunomodulatory effects. The aim of the current review was to assess the effectiveness of probiotic supplements and colchicine on symptoms, duration, and progression of mild and moderate cases of COVID-19 infection. Review: A randomized, double-blind, placebo-controlled trial in the United States with 182 participants who were randomly assigned to receive daily oral probiotic (Lactobacillus rhamnosus) LGG or placebo for 28 days. The study indicated that LGG is well-tolerated and is associated with a delay in the onset of COVID-19 infection, a reduction in the incidence of symptoms, and alterations in the structure of the gut microbiome when administered as post-exposure prophylaxis within seven days of exposure. Colchicine may lessen mortality and the need for mechanical ventilation in mild-to-moderate COVID-19 patients, according to a systematic review and meta-analysis. Conclusion: Probiotics and/or colchicine may be viable treatment options for COVID-19 patients. To examine the efficacy of probiotics and colchicine in the treatment of COVID-19, it is necessary to conduct additional clinical trials and provide clinicians with evidence, as there are currently insufficient studies to support this conclusion.},
}
%0 Journal Article
%A Hassan, Samar Osama Ahmed
%A Hassan, Ahmed Nour El-Din
%A Mohamed, Manal Sabry
%A Nessim, Mina Mikhail
%A Ashram, Mohamed Nabil Badawy Al
%A Allam, Mohamed Farouk
%D 2023
%J Universal Journal of Stomatology
%@ ISSN Pending
%V 1
%N 1
%P 14-16
%T Role of Probiotics and Colchicine in COVID-19 Management?
%M doi:10.31586/ujgh.2023.772
%U https://www.scipublications.com/journal/index.php/UJGH/article/view/772
TY - JOUR
AU - Hassan, Samar Osama Ahmed
AU - Hassan, Ahmed Nour El-Din
AU - Mohamed, Manal Sabry
AU - Nessim, Mina Mikhail
AU - Ashram, Mohamed Nabil Badawy Al
AU - Allam, Mohamed Farouk
TI - Role of Probiotics and Colchicine in COVID-19 Management?
T2 - Universal Journal of Stomatology
PY - 2023
VL - 1
IS - 1
SN - ISSN Pending
SP - 14
EP - 16
UR - https://www.scipublications.com/journal/index.php/UJGH/article/view/772
AB - Background: Coronavirus disease 2019 (COVID-19) is a newly emerging human disease caused by a novel coronavirus, causing a global pandemic crisis. Probiotics and/or colchicine may be considered as options for treatment since they have anti-viral, anti-inflammatory, and immunomodulatory effects. The aim of the current review was to assess the effectiveness of probiotic supplements and colchicine on symptoms, duration, and progression of mild and moderate cases of COVID-19 infection. Review: A randomized, double-blind, placebo-controlled trial in the United States with 182 participants who were randomly assigned to receive daily oral probiotic (Lactobacillus rhamnosus) LGG or placebo for 28 days. The study indicated that LGG is well-tolerated and is associated with a delay in the onset of COVID-19 infection, a reduction in the incidence of symptoms, and alterations in the structure of the gut microbiome when administered as post-exposure prophylaxis within seven days of exposure. Colchicine may lessen mortality and the need for mechanical ventilation in mild-to-moderate COVID-19 patients, according to a systematic review and meta-analysis. Conclusion: Probiotics and/or colchicine may be viable treatment options for COVID-19 patients. To examine the efficacy of probiotics and colchicine in the treatment of COVID-19, it is necessary to conduct additional clinical trials and provide clinicians with evidence, as there are currently insufficient studies to support this conclusion.
DO - Role of Probiotics and Colchicine in COVID-19 Management?
TI - 10.31586/ujgh.2023.772
ER -
